Is a complete SBFM research report available?

No complete published report is available for Sunshine Biopharma, Inc. (SBFM) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Sunshine Biopharma, Inc. (SBFM)

NASDAQ: SBFM · USD

$1.66

-0.05 (-2.9%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-26 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first SBFM analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	2.7M
Revenue (ttm)	35.5M
Net income (ttm)	-6M
EPS (ttm)	-$12.8
Shares out	1.6M
Volume	23,375.464
Beta	1.31

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 35.5M
Net income (ttm): -6M
EPS (ttm): -$12.8
Market cap: 2.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All SBFM indicators

Market & fundamental data

Available fields

209

Groups with data

Currency

USD

Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001402328
Company name	Sunshine Biopharma, Inc.
Country	United States
Country code	US
Cusip	867781809
Employees	50
Employees Change	-2%
Employees Change Percent	-3.85
Enterprise value	$-3.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	126.3
Industry PE Fwd	14.06
Isin	US8677818093
Last refreshed	2026-07-26
Market cap	$2.7M
Market cap category	Nano-Cap
Price	$1.66
Price currency	USD
Rev Per Employee	709,866.3x
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.79
Sic	2834
Symbol	SBFM
Website	https://sunshinebiopharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-225.05%
FCF yield	-219.12%
P/B ratio	0.04x
P/S ratio	0.08x
PS Forward	0.1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-17.33%
EBITDA Margin	-16.36%
Gross margin	32.98%
Gross Profit	$11.7M
Gross Profit Growth	5.98%
Gross Profit Growth Q	-20.12%
Gross Profit Growth3 Y	50.1%
Gross Profit Growth5 Y	187.23%
Net Income	$-6M
Net Income Growth Years	0%
Pretax Margin	-16.84%
Profit Margin	-17.02%
Profit Per Employee	$-120,789
ROA	-10.02
Roa5y	-32.15
ROCE	-27.89
ROE	-27.32
ROIC	-12.47

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-79.45%
Cagr15y	-74.8%
Cagr1y	-89.51%
Cagr3y	-94.41%
Cagr5y	-91.86%
EPS Growth Quarters	1
EPS Growth Years	4
Revenue Growth	-2.05x
Revenue Growth Q	-9.13x
Revenue Growth Years	6x
Revenue Growth3 Y	57.31x
Revenue Growth5 Y	223.38x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.24
Assets	$27.9M
Cash	$7M
Current Assets	$24.8M
Current Liabilities	$5.9M
Debt	$744,840
Debt Equity	$0.03
Equity	$21.5M
Liabilities	$6.4M
Long Term Assets	$3.1M
Long Term Liabilities	$535,614
Net Cash	$6.2M
Net Cash By Market Cap	$233
Net Cash Growth	-14.04%
Net Debt Equity	$-0.29
Tangible Book Value	$19.6M
Tangible Book Value Per Share	$39.92
WACC	8.96

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.22
Inventory Turnover	1.9
Net Working Capital	$12.1M
Quick ratio	1.87
Working Capital	$18.9M
Working Capital Turnover	$1.89

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-286.75%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-100%
1Y total return	-89.49%
200-day SMA	10.5
3Y total return	-99.98%
50-day SMA	2.64
50-day SMA vs 200-day SMA	50under200
5Y total return	-100%
All Time High	2,416,666,666.7
All Time High Change	-100%
All Time High Date	2011-08-02
All Time Low	1.66
All Time Low Change	0%
All Time Low Date	2026-07-24
ATR	0.22
Beta	1.31
Beta1y	1.41
Beta2y	1.68
Ch YTD	-86.5
High	1.76
High52	24.3
High52 Date	2025-10-16
High52ch	-93.17%
Low	1.66
Low52	1.66
Low52 Date	2026-07-24
Low52ch	0%
Ma50ch	-37%
Premarket Change Percent	2.97
Premarket Price	$1.76
Premarket Volume	1,432
Price vs 200-day SMA	-84.18%
RSI	28.65
RSI Monthly	37.12
RSI Weekly	22.92
Sharpe ratio	-1.18x
Sortino ratio	-1.78
Total Return	-286.75%
Tr YTD	-86.5
Tr15y	-100%
Tr1m	-18.63%
Tr1w	-7.78%
Tr3m	-83.23%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-1.2
Earnings Revenue Estimate	8,600,000x
Earnings Revenue Estimate Growth	-8.61x
Operating Income	$-4.6M
Operating margin	-12.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,606,395%
Float Percent	99.37%
Shares Insiders	0.63%
Shares Institutions	2.72%
Shares Out	1,616,594
Shares Qo Q	1.1%
Shares Yo Y	286.75%
Short Float	7.06%
Short Ratio	0.13
Short Shares	7.02

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-5.9M
Average Volume	49,543.3x
Bv Per Share	43.83
CAPEX	$-172,130
Ch10y	-100
Ch15y	-100
Ch1m	-18.63
Ch1w	-7.78
Ch1y	-89.49
Ch3m	-83.23
Ch3y	-99.98
Ch5y	-100
Ch6m	-86.5
Change	-2.92%
Change From Open	-2.92
Close	1.71
Days Gap	0
Depreciation Amortization	344,136
Dollar Volume	38,803.3
Earnings Date	2026-08-11
Earnings Time	amc
EBIT	$-6.2M
EBITDA	$-5.8M
EPS	$-12.83
F Score	3
FCF	$-5.9M
FCF EV Yield	165.35x
FCF Per Share	$-3.64
Financing CF	4,393,111
Fiscal Year End	December
Founded	2,006
Income Tax	$61,770
Investing CF	-728,807
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-13
Last Report Date	2026-03-31
Last Split Date	2026-06-01
Last Split Type	Reverse
Last10k Filing Date	2026-04-03
Ma150	8.53
Ma150ch	-80.55%
Ma20	1.97
Ma20ch	-15.56%
Net CF	-1,211,597
Next Earnings Date	2026-08-11
Open	1.71
Optionable	No
Position In Range	0
Post Close	1.66
Postmarket Change Percent	0.6
Postmarket Price	$1.67
Ppne	1,229,387
Pre Close	1.71
Price Date	2026-07-24
Ptbv Ratio	0.14
Relative Volume	0.47x
Revenue	35,493,315x
Tax By Revenue	0.17x
Tr6m	-86.5%
Us State	Florida
Volume	23,375.5
Z Score	-1.67

Sunshine Biopharma, Inc. (SBFM)

Coverage state: Market snapshot only — no published research

Generate the first SBFM analysis

Price

Financial snapshot

Fair-value bridge

Latest news · SBFM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SBFM indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on SBFM

Frequently asked questions